We honor the life and legacy of Dr. Martin Luther King Jr., an innovative leader whose commitment to justice, equality, and unity transformed our nation. Dr. King's message of hope and his call to serve others remind us of the importance of treating every individual with dignity

"Michael’s addition to our team underscores our commitment to becoming a leader in real estate and mortgage finance," said EVP, Head of Investment Banking & Capital Markets, Burke Dempsey. Read below from @GillianTan at @business to see how Managing Director, Investment.

Today, the @NYSE and @Nasdaq are closed in observance of a National Day of Mourning for former President Jimmy Carter, who passed away at the age of 100. President Carter's legacy of humanitarianism and public service continues to inspire us all. We recognize this longstanding

Equity Research Analyst, Yun Zhong, PhD, initiated coverage on Rocket Pharmaceuticals ($RCKT) at #OUTPERFORM, setting a 12-month price target of $32.00. Looking into the new year, Yun believes 2025 will be an "inflection" year, "with multiple clinical/regulatory catalysts

Equity Research Analyst, @DivesTech, recently initiated coverage on five new names:.- Lithium Americas Corp ($LAC) at #NEUTRAL.- Oklo Inc ($OKLO) at #OUTPERFORM.- Innodata Inc. ($INOD) at #OUTPERFORM.- OneStream Inc. ($OS) at #OUTPERFORM.- SolarWinds Corp ($SWI) at #OUTPERFORM

Equity Research Analyst, Scott Devitt, initiated coverage on Xometry, Inc. ($XMTR) at #OUTPERFORM, setting a 12-month price target of $48.00. As the "leading digital marketplace for custom manufacturing," Xometry is "well-positioned to take share within the global custom

#TBT to 2013 when our analysts at Wedbush were ahead of the curve, predicting @Bitcoin could reach $100,000 in value. This milestone was detailed in our report: “Bitcoin: Intrinsic Value as Conduit for Disruptive Payment Network Technology.” ₿. Read the full report here:

Equity Research Analyst, Seth Basham, CFA® initiated coverage on Monro, Inc. ($MNRO) at #OUTPERFORM, setting a 12-month price target of $31.00. With the pivot to selling lower-tier tires and efforts to drive traffic in oil changes gaining momentum, Seth and his team "believe the

Equity Research Analyst, Jay McCanless, initiated coverage on Hovnanian Enterprises, Inc ($HOV) at #NEUTRAL, setting a 12-month price target of $155.00. Jay and his team "believe the shares reflect the improved balance sheet." . Read more about Jay's coverage universe here:

Equity Research Analyst, Richard Anderson, initiated coverage on Centerspace ($CSR) at #NEUTRAL, setting a 12-month price target of $72.00. "CSR continues to evolve, from its diversified property type roots that once drafted off the North Dakota fracking boom (circa 2012), to the

RT @RonStoeferle: KUDOS to the analysts at @Wedbush for putting out such a great piece on #Bitcoin 11 years ago, forecasting a 100,000 BTC….

Equity Research Analyst, Laura Chico, Ph.D., initiated coverage on Solid Biosciences Inc. ($SLDB) at #OUTPERFORM, setting a 12-month price target of $16.00. With shares trading "near a ~$200M valuation, and with near-term SGT-003 data approaching in 1Q25, we do see levers for